Health Economics – Strategy & Budget Impact Modelling from HEOR Specialists

Evaluating the economic case for a product is at the core of many Reimbursement and Health Technology Assessment processes worldwide; therefore, developing a robust and appropriate economic argument is crucial to commercial success.

Types of Health economic modelling

We can conceptualise, develop and critically appraise all health economic model types, including:

  • Decision tree modelling, Markov and semi-Markov modelling, partitioned survival, discrete event simulations conceptual modelling, and regression-based modelling.
  • Cost-effectiveness, cost-utility, cost-minimisation, cost-consequence and budget impact models.

How are health economic models used to support market access?

Early-stage models and evaluation

Early-stage models allow pharmaceutical and biotech companies to understand the potential cost effectiveness or budget impact of a new product whilst it is still in early phase trials. An early model can:

  • Identify data gaps so that clinical/non-clinical evidence can be collected accordingly
  • Inform ‘go / no-go’ decisions
  • Present the opportunity to test modelling methodology and underlying assumptions with key opinion leaders (KOLs)
  • Inform an appropriate pricing strategy

Supporting launch and market access strategy

Health Economic models are used to support the development and implementation of market access, pricing and commercial strategy at both global and national levels. As such, a model may be:

  • Featured within a global value dossier
  • Used to evaluate and determine pricing strategy
  • Used to support the development of global and local value propositions
  • Adapted to reflect local markets

Models for Health Technology Assessments

A health economic model is a requirement for most reimbursement and health technology assessment (HTA) submissions. Within submissions, cost-effectiveness, cost-utility, cost-consequence, or budget impact models may be used to demonstrate the potential impact of the product on healthcare budgets and patient outcomes.

The model is one of the most influential parts of the submission – in many European markets, demonstrating cost-effectiveness is a pre-requisite for reimbursement. It is important to ensure that the right type of model is chosen, the principles and data are transparent, and that the economic argument is demonstrated clearly.

Engaging with local payers and healthcare decision-makers

Budget impact models are also used as conversation aids with payers, prescribers, and other healthcare decision-makers to present the potential financial impact of a new product. These models are often adapted to reflect local pricing and formulary data and other market nuances.

The best models are interactive and developed on a suitable platform (Mtech Access can develop budget impact models in Excel, on iPad, or hosted on a website), enabling the account manager to adapt key parameters to reflect the payer’s specific circumstances.

Our specialist health economic consultants use the latest modelling techniques and methods to ensure that all our models are robust and fit-for-purpose in today’s challenging environment.

To discuss your Health Economics needs with our experts, get in touch using the form below.

    Why choose Mtech Access as your health economics consultancy?

    135
    projects
    40
    Clients
    75
    years' experience
    • We are leaders in:
      • Cost-effectiveness modelling: Early (global) models and HTA-specific models
      • Budget impact modelling for national or local discussion
      • Critiques of existing models
      • Supporting statistical analysis
      • Technical documentation
      • Manuscript writing
    • We have worked on 135+ projects* with 40+ clients
    • Our team collectively have 75+ years’ experience building health economic models to support reimbursement and market access
    • We develop our own health economic models as well as critiquing and adapting models developed by other agencies
    • We build early-stage health economic models and evaluations to support your global strategy or for inclusion in a global value dossier
    • We are also experienced in submission-ready cost-effectiveness models and budget impact models to support your Health Technology Assessment, with the skills in-house to support your full submission or to supplement your teams’ capability where needed
    • Our customer communication experts and in-house developers can develop your model into an interactive digital tool that can be housed on the iPad, presented remotely via the web, and integrated with CRM systems, such as Veeva
    • We confirm the principles and assumptions behind our models with a broad network of payers, clinicians, and other stakeholders across global markets
    • In the UK we have close relationships with over 90 contracted Associates working in the NHS, who work directly with us on projects, to help us ensure our models will resonate with NHS decision-makers

    *Includes any distinct project involving the evaluation or build of a health economic model for an external Pharmaceutical, Medtech, Biotech Diagnostics or Healthcare client.

    • We are leaders in:
      • Cost-effectiveness modelling: Early (global) models and HTA-specific models
      • Budget impact modelling for national or local discussion
      • Critiques of existing models
      • Supporting statistical analysis
      • Technical documentation
      • Manuscript writing
    • We have worked on 135+ projects* with 40+ clients
    • Our team collectively have 75+ years’ experience building health economic models to support reimbursement and market access
    • We develop our own health economic models as well as critiquing and adapting models developed by other agencies
    • We build early-stage health economic models and evaluations to support your global strategy or for inclusion in a global value dossier
    • We are also experienced in submission-ready cost-effectiveness models and budget impact models to support your Health Technology Assessment, with the skills in-house to support your full submission or to supplement your teams’ capability where needed
    • Our customer communication experts and in-house developers can develop your model into an interactive digital tool that can be housed on the iPad, presented remotely via the web, and integrated with CRM systems, such as Veeva
    • We confirm the principles and assumptions behind our models with a broad network of payers, clinicians, and other stakeholders across global markets
    • In the UK we have close relationships with over 80 contracted Associates working in the NHS, who work directly with us on projects, to help us ensure our models will resonate with NHS decision-makers

    *Includes any distinct project involving the evaluation or build of a health economic model for an external Pharmaceutical, Medtech, Biotech Diagnostics or Healthcare client.

    Articles related to health economics

    Conceptualising and building health economic models at Mtech Access – An interview with Claire Spencer

    Claire Spencer, Health Economist in our Manchester office, gives an insight into her day-to-day work and the different projects she works on at Mtech Access. These include both commercial and…

    The value of early-stage health economic models - an interview with Elizabeth Thurgar - Director, Health Economics

    The value of early-stage health economic models – an interview with Elizabeth Thurgar

    Elizabeth Thurgar recently joined Mtech Access as a Director in our Health Economics team. In this interview, she tells us about her experiences and activities in her first few weeks…

    How health economic modelling can help MedTech Innovations reach patients Cover Photo

    How health economic modelling can help MedTech innovations reach patients – an interview with Calum Jones

    Calum Jones, Consultant Health Economist at Mtech Access, shares his passion for helping MedTech firms build health economic models that help their innovative new technologies reach patients. Tell us about…